RT Journal Article SR Electronic T1 Let it bud: an ultrastructural study of Cryptococcus neoformans surface during budding events JF bioRxiv FD Cold Spring Harbor Laboratory SP 2020.05.15.098913 DO 10.1101/2020.05.15.098913 A1 Glauber R. de S. Araújo A1 Carolina de L. Alcantara A1 Noêmia Rodrigues A1 Wanderley de Souza A1 Bruno Pontes A1 Susana Frases YR 2020 UL http://biorxiv.org/content/early/2020/05/16/2020.05.15.098913.abstract AB Cryptococcus neoformans is a fungal pathogen that causes life-threatening infections in immunocompromised individuals. It is surrounded by three concentric structures that separate the cell from the extracellular space: the plasma membrane, the cell wall and the polysaccharide capsule. Although several studies have revealed the chemical composition of these structures, little is known about their ultrastructural organization and remodeling during C. neoformans budding event. Here, by combining the state-of-the-art in light and electron microscopy techniques we describe the morphological remodeling that occurs synergistically among the capsule, cell wall and plasma membrane during budding in C. neoformans. Our results show that the cell wall deforms to generate a specialized budding region at one of the cell’s poles. This region subsequently begins to break into layers that are slightly separated from each other and with thick tips. We also observe a reduction in density of the capsular polysaccharide around these specialized regions. Daughter cells present a distinct spatial organization, with polysaccharide fibers aligned in the direction of budding. In addition, to control the continuous openings between mother and daughter cells, the latter developed a strategy to shield themselves by forming multilamellar membrane structures in conjunction with their capsules. Together, our findings provide compelling ultrastructural evidence for a dynamic C. neoformans surface remodeling during budding and may have important implications for future studies exploring these remodeled specialized regions as drug-targets against cryptococcosis.Competing Interest StatementThe authors have declared no competing interest.